Goodman Advisory Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-127
Closed -$13.1K 168
2023
Q3
$13.1K Sell
127
-44
-26% -$4.74K ﹤0.01% 122
2023
Q2
$19.7K Sell
171
-4,141
-96% -$470K 0.01% 105
2023
Q1
$459K Sell
4,312
-25,162
-85% -$2.72M 0.25% 35
2022
Q4
$3.27M Sell
29,474
-679
-2% -$69.4K 1.9% 15
2022
Q3
$2.6M Sell
30,153
-8,938
-23% -$798K 1.42% 16
2022
Q2
$3.56M Buy
+39,091
New +$3.47M 1.59% 11

Other funds holding MRK

Goodman Advisory Group's MRK Position: Q4 2023 in Review

Goodman Advisory Group sold out of Merck (MRK) in Q4 2023, closing a stake of 127 shares — an estimated $13.1K sold.

Goodman Advisory Group first reported a position in MRK in Q2 2022 and held it in 6 quarters. The position peaked at $3.56M in Q2 2022. 3,434 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • Goodman Advisory Group reported no remaining Merck position as of Q4 2023 after selling out during the quarter.
  • Goodman Advisory Group sold 127 Merck shares in Q4 2023, an estimated $13.1K.
  • Goodman Advisory Group first reported a position in Merck in Q2 2022 and held it in 6 quarters.
  • Goodman Advisory Group's Merck position peaked at $3.56M in Q2 2022.
  • 3,434 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on Goodman Advisory Group's 13F filing for Q4 2023, filed 31 Jan 2024.